G71.14
Drug induced myotonia
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Drug-induced myotonia is a condition characterized by the abnormal delayed relaxation of muscles caused by certain medications. This condition results in muscles that feel stiff or difficult to relax after contraction. It is a rare side effect linked to specific drugs and can affect various muscles in the body, impacting daily activities and quality of life. Recognizing the symptoms and understanding the underlying causes can help in managing this condition effectively.
Causes & Symptoms
Clinical Causes: Use of specific medications such as certain antidepressants, antipsychotics, or drugs used for neurological conditions Long-term use or high doses of drugs that interfere with muscle relaxation processes Patient-specific factors including genetic predisposition or underlying neuromuscular conditions that may increase susceptibility
Key Symptoms: Muscle stiffness, especially after movement Delayed muscle relaxation following contraction General muscle fatigue Muscle cramps or spasms Difficulty releasing grip or extending limbs after holding a position Potential weakness in affected muscles
Diagnostic & Treatment
Diagnosis Path: Diagnosis of drug-induced myotonia involves a combination of medical history review, including current medications, and clinical examination. Healthcare providers may perform specialized tests such as electromyography (EMG) to assess muscle activity and confirm the presence of myotonia. Blood tests might also be conducted to rule out other neuromuscular disorders. An important aspect of diagnosis is recognizing a temporal relationship between the initiation of specific drugs and the onset of symptoms.
Treatment Protocols: Discontinuing or substituting the medication responsible for myotonia, under medical supervision Symptomatic treatment with medications that reduce muscle stiffness, such as certain muscle relaxants Physical therapy to improve muscle flexibility and strength Monitoring and regular follow-up to assess symptom resolution and prevent recurrence
Clinical Advice & FAQs
Billing Guidance
Is G71.14 a billable ICD-10 code?
Yes, G71.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G71.14?
Clinical documentation must specify the nature of Drug induced myotonia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference